Showing results (31-40 of 64) with videos related to
Sort By:
Pageof 7
BMJ Open Diabetes Research & Care|December 30, 2022
Treatment patterns and satisfaction in patients with type 2 diabetes newly initiating oral monotherapy with antidiabetic drugs in Japan: results from the prospective Real-world Observational Study on Patient Outcomes in Diabetes (RESPOND)Atsushi Tajima, Keisuke Tobe, Jun-Ichi Eiki, et al.Diabetes, Obesity & Metabolism|May 18, 2018
Effect of short-term treatment with sitagliptin or glibenclamide on daily glucose fluctuation in drug-naïve Japanese patients with type 2 diabetes mellitusRyo Suzuki, Jun-Ichi Eiki, Takashi Moritoyo, et al.European Journal of Pharmacology|December 1, 2005
Detailed pharmacological characterization of GT-2331 for the rat histamine H3 receptorSayaka Ito, Ryo Yoshimoto, Yasuhisa Miyamoto, et al.Bioorganic & Medicinal Chemistry Letters|July 15, 2009
Design, synthesis and evaluation of a novel cyclohexanamine class of neuropeptide Y Y1 receptor antagonistsKaimei Cho, Makoto Ando, Kensuke Kobayashi, et al.Journal of Biochemistry|June 10, 2009
Identification and characterization of a selective radioligand for ELOVL6Ken Shimamura, Hidekazu Takahashi, Hidefumi Kitazawa, et al.Peptides|May 26, 2009
(-)-Ternatin inhibits adipogenesis and lipid metabolism in 3T3-L1 cellsMasahiko Ito, Junko Ito, Hidefumi Kitazawa, et al.BMJ Open Diabetes Research & Care|November 14, 2020
Real-world Observational Study on Patient Outcomes in Diabetes (RESPOND): study design and baseline characteristics of patients with type 2 diabetes newly initiating oral antidiabetic drug monotherapy in JapanDaisuke Yabe, Hiroko Higashiyama, Takashi Kadowaki, et al.BMJ Open|September 14, 2022
Demographic and clinical characteristics of patients with delirium: analysis of a nationwide Japanese medical databaseNaoya Ueda, Masakazu Igarashi, Kotoba Okuyama, et al.Diabetology International|January 21, 2022
Patient characteristics associated with improvement in glycemic control following addition of an oral antidiabetic drug to DPP-4 inhibitor monotherapy in Japanese patients with type 2 diabetes mellitus (JDDM 60)Koichi Kawai, Jun-Ichi Eiki, Azuma Kanatsuka, et al.BMJ Open|December 15, 2022
Incremental medical cost of delirium in elderly patients with cognitive impairment: analysis of a nationwide administrative database in JapanMasakazu Igarashi, Kotoba Okuyama, Naoya Ueda, et al.Pageof 7